LIQT:NASDAQLiqTech International, Inc. Analysis
Data as of 2026-04-15 - not real-time
$1.86
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: The stock trades above its short‑term moving averages while staying below its long‑term average, with the momentum indicator turning bullish and the relative strength index in neutral territory. Volatility is extremely high and trading volume has been on a downtrend, suggesting price swings may continue.
Fundamental backdrop: The company reports negative profitability margins, a sizable debt load relative to equity, and cash that is insufficient to cover its liabilities. Recent news notes a modest revenue rebound and ambitious growth plans, yet the latest earnings missed expectations, underscoring the ongoing earnings challenges. The market currently values the shares at a discount to book and sales multiples, and analysts project a substantial upside, though the lack of dividend and weak cash generation heighten risk.
Fundamental backdrop: The company reports negative profitability margins, a sizable debt load relative to equity, and cash that is insufficient to cover its liabilities. Recent news notes a modest revenue rebound and ambitious growth plans, yet the latest earnings missed expectations, underscoring the ongoing earnings challenges. The market currently values the shares at a discount to book and sales multiples, and analysts project a substantial upside, though the lack of dividend and weak cash generation heighten risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price above short‑term averages but below long‑term trend
- bullish momentum signal
- high volatility and decreasing volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- recent revenue uplift and stated growth initiatives
- persistent earnings losses and high leverage
- valuation gap suggesting potential upside
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- fundamental restructuring needed to achieve profitability
- exposure to environmental regulation could drive demand
- significant balance‑sheet risk may limit upside
Key Metrics & Analysis
Financial Health
Revenue Growth-8.20%
Profit Margin-51.66%
P/E Ratio-3.3
ROE-63.66%
ROA-17.39%
Debt/Equity128.74
P/B Ratio1.7
Op. Cash Flow$-6108176
Free Cash Flow$-3869788
Industry P/E31.2
Technical Analysis
TrendNeutral
RSI56.4
Support$1.22
Resistance$2.04
MA 20$1.73
MA 50$1.66
MA 200$1.98
MACDBullish
VolumeDecreasing
Fear & Greed Index88.64
Valuation
Target Price$4.30
Upside/Downside131.18%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.75
Volatility111.50%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.